INDBInternet News Database 2.5 Updated 2 min ago · 288 sources Show or hide images Light or dark

Berkshire Hathaway Sells $69M of DaVita Stock Amid HHS Kidney Reforms, Securities Fraud Probe

1 source1 article First seen Updated United Kingdom Truth score 38

Save Like Comments Compare coverage

Summary

Berkshire Hathaway sold $69 million in DaVita shares as HHS unveils a kidney-care plan and Pomerantz investigates potential securities fraud.

Description from Ibtimes.

Who is covering this

  1. Ibtimes Center Factuality: Mostly factual GB
    Berkshire Hathaway Sells $69M of DaVita Stock Amid HHS Kidney Reforms, Securities Fraud Probe

    Berkshire Hathaway sold $69 million in DaVita shares as HHS unveils a kidney-care plan and Pomerantz investigates potential securities fraud.

Comments

Comments need JavaScript.